Accuray Incorporated (ARAY)
USD 1.79
(-6.28%)
USD 1.79
(-6.28%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 142.41 Million USD | -6.04% |
| 2023 | 151.57 Million USD | -0.15% |
| 2022 | 151.8 Million USD | 10.59% |
| 2021 | 137.27 Million USD | -0.53% |
| 2020 | 138 Million USD | -14.85% |
| 2019 | 162.06 Million USD | -2.07% |
| 2018 | 165.49 Million USD | 9.48% |
| 2017 | 151.16 Million USD | -7.59% |
| 2016 | 163.58 Million USD | -0.6% |
| 2015 | 164.57 Million USD | 2.25% |
| 2014 | 160.94 Million USD | -9.73% |
| 2013 | 178.29 Million USD | -10.97% |
| 2012 | 200.25 Million USD | 47.77% |
| 2011 | 135.52 Million USD | 33.94% |
| 2010 | 101.18 Million USD | -14.04% |
| 2009 | 117.7 Million USD | 9.1% |
| 2008 | 107.88 Million USD | 21.8% |
| 2007 | 88.57 Million USD | 50.4% |
| 2006 | 58.89 Million USD | 62.95% |
| 2005 | 36.14 Million USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 15.56 Million USD | 162.9% |
| 2002 | -24.75 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 31.63 Million USD | -5.95% |
| 2024 FY | 142.41 Million USD | -6.04% |
| 2024 Q1 | 37.28 Million USD | -2.24% |
| 2024 Q2 | 39.86 Million USD | 6.94% |
| 2024 Q3 | 33.63 Million USD | -15.63% |
| 2023 Q1 | 36.77 Million USD | -10.23% |
| 2023 Q4 | 38.13 Million USD | 4.76% |
| 2023 Q3 | 36.4 Million USD | -9.59% |
| 2023 Q2 | 40.26 Million USD | 9.47% |
| 2023 FY | 151.57 Million USD | -0.15% |
| 2022 Q4 | 40.97 Million USD | 16.81% |
| 2022 Q3 | 35.07 Million USD | -9.24% |
| 2022 FY | 151.8 Million USD | 10.59% |
| 2022 Q1 | 37.11 Million USD | -6.25% |
| 2022 Q2 | 38.64 Million USD | 4.13% |
| 2021 Q4 | 39.58 Million USD | 12.74% |
| 2021 Q1 | 29.93 Million USD | -15.29% |
| 2021 FY | 137.27 Million USD | -0.53% |
| 2021 Q2 | 32.63 Million USD | 9.01% |
| 2021 Q3 | 35.11 Million USD | 7.61% |
| 2020 Q1 | 37.22 Million USD | -12.76% |
| 2020 Q2 | 34.27 Million USD | -7.91% |
| 2020 Q3 | 31.16 Million USD | -9.08% |
| 2020 Q4 | 35.34 Million USD | 13.4% |
| 2020 FY | 138 Million USD | -14.85% |
| 2019 Q4 | 42.66 Million USD | 13.52% |
| 2019 FY | 162.06 Million USD | -2.07% |
| 2019 Q1 | 42.56 Million USD | -5.18% |
| 2019 Q2 | 39.24 Million USD | -7.8% |
| 2019 Q3 | 37.58 Million USD | -4.24% |
| 2018 Q1 | 40.15 Million USD | -0.53% |
| 2018 Q2 | 40.37 Million USD | 0.53% |
| 2018 FY | 165.49 Million USD | 9.48% |
| 2018 Q3 | 40.07 Million USD | -0.75% |
| 2018 Q4 | 44.89 Million USD | 12.03% |
| 2017 FY | 151.16 Million USD | -7.59% |
| 2017 Q4 | 40.37 Million USD | 10.02% |
| 2017 Q3 | 36.69 Million USD | 1.33% |
| 2017 Q1 | 37.89 Million USD | -5.88% |
| 2017 Q2 | 36.21 Million USD | -4.44% |
| 2016 Q2 | 42.69 Million USD | 13.13% |
| 2016 Q1 | 37.74 Million USD | -9.99% |
| 2016 Q3 | 39.5 Million USD | -7.48% |
| 2016 Q4 | 40.26 Million USD | 1.92% |
| 2016 FY | 163.58 Million USD | -0.6% |
| 2015 Q2 | 42.08 Million USD | -2.31% |
| 2015 FY | 164.57 Million USD | 2.25% |
| 2015 Q4 | 41.93 Million USD | 11.85% |
| 2015 Q3 | 37.48 Million USD | -10.91% |
| 2015 Q1 | 43.07 Million USD | -0.1% |
| 2014 Q3 | 40.17 Million USD | 3.32% |
| 2014 Q1 | 38.76 Million USD | -3.11% |
| 2014 Q2 | 38.88 Million USD | 0.32% |
| 2014 Q4 | 43.11 Million USD | 7.3% |
| 2014 FY | 160.94 Million USD | -9.73% |
| 2013 Q4 | 40.01 Million USD | -11.26% |
| 2013 Q1 | 46.36 Million USD | -12.75% |
| 2013 Q3 | 45.08 Million USD | -7.78% |
| 2013 Q2 | 48.89 Million USD | 5.45% |
| 2013 FY | 178.29 Million USD | -10.97% |
| 2012 FY | 200.25 Million USD | 47.77% |
| 2012 Q4 | 53.14 Million USD | 5.35% |
| 2012 Q1 | 49.11 Million USD | -14.64% |
| 2012 Q2 | 47.55 Million USD | -3.18% |
| 2012 Q3 | 50.44 Million USD | 6.08% |
| 2011 Q4 | 57.53 Million USD | 106.68% |
| 2011 Q3 | 27.83 Million USD | 7.98% |
| 2011 Q2 | 25.78 Million USD | 5.81% |
| 2011 Q1 | 24.36 Million USD | -2.78% |
| 2011 FY | 135.52 Million USD | 33.94% |
| 2010 Q4 | 25.06 Million USD | 10.81% |
| 2010 Q3 | 22.61 Million USD | -19.97% |
| 2010 Q2 | 28.26 Million USD | 11.97% |
| 2010 Q1 | 25.24 Million USD | -5.69% |
| 2010 FY | 101.18 Million USD | -14.04% |
| 2009 Q4 | 26.76 Million USD | -9.27% |
| 2009 Q2 | 28.77 Million USD | -11.91% |
| 2009 Q1 | 32.66 Million USD | 18.89% |
| 2009 FY | 117.7 Million USD | 9.1% |
| 2009 Q3 | 29.5 Million USD | 2.52% |
| 2008 Q4 | 27.47 Million USD | 0.4% |
| 2008 Q2 | 27.27 Million USD | 5.82% |
| 2008 FY | 107.88 Million USD | 21.8% |
| 2008 Q1 | 25.77 Million USD | 1.72% |
| 2008 Q3 | 27.36 Million USD | 0.35% |
| 2007 FY | 88.57 Million USD | 50.4% |
| 2007 Q1 | 18.33 Million USD | 121.22% |
| 2007 Q2 | 22.03 Million USD | 20.19% |
| 2007 Q3 | 22.88 Million USD | 3.85% |
| 2007 Q4 | 25.33 Million USD | 10.73% |
| 2006 Q3 | 24 Million USD | 26.32% |
| 2006 Q1 | - USD | 100.0% |
| 2006 FY | 58.89 Million USD | 62.95% |
| 2006 Q2 | 19 Million USD | 0.0% |
| 2006 Q4 | -86.38 Million USD | -459.95% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | -47.26 Million USD | 0.0% |
| 2005 FY | 36.14 Million USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2003 FY | 15.56 Million USD | 162.9% |
| 2002 FY | -24.75 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Envoy Medical, Inc. | 17.89 Million USD | -695.715% |
| Delcath Systems, Inc. | 39.61 Million USD | -259.53% |
| Xylo Technologies Ltd. | 35.16 Million USD | -305.031% |